PEAK6 Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

PEAK6 Group’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$31K	Buy	+330	New	+$28.4K	﹤0.01%	4017
2017 Q3	–	Sell	-9,096	Closed	-$682K	–	5261
2017 Q2	$682K	Buy	+9,096	New	+$631K	﹤0.01%	2253
2016 Q4	–	Sell	-2,690	Closed	-$152K	–	5242
2016 Q3	$152K	Buy	+2,690	New	+$132K	﹤0.01%	3335
2015 Q4	–	Sell	-4,892	Closed	-$190K	–	5510
2015 Q3	$190K	Buy	+4,892	New	+$196K	﹤0.01%	3787

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Group's PRAH Position: Q2 2018 in Review

PEAK6 Group opened a new position in PRA Health Sciences, Inc. (PRAH) in Q2 2018: 330 shares worth $31K. The stake represents ﹤0.01% of the portfolio and ranks #4017 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in PRAH as recently as Q2 2017.

PEAK6 Group first reported a position in PRAH in Q3 2015 and has held it in 4 quarters since. The position peaked at $682K in Q2 2017. 300 funds tracked by Wall St. Rank hold PRAH as of Q2 2018.

PEAK6 Group held 330 shares of PRA Health Sciences, Inc. worth $31K as of Q2 2018.
PRA Health Sciences, Inc. was a new PEAK6 Group position in Q2 2018.
PRA Health Sciences, Inc. made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #4017 holding.
PEAK6 Group first reported a position in PRA Health Sciences, Inc. in Q3 2015 and has held it in 4 quarters since.
PEAK6 Group's PRA Health Sciences, Inc. position peaked at $682K in Q2 2017.
300 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.